SCHEMBL5741480

SCHEMBL5741480

COc1ccc(C(C)(OC)C(=O)O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.50
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
ALOX15 P16050 1/20 0.49
APEX1 P27695 1/20 0.49
MAPK1 P28482 1/20 0.49
RECQL P46063 1/20 0.49
HSD17B10 Q99714 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
CA1 P00915 6/20 0.48
CA2 P00918 6/20 0.48
CES2 O00748 2/20 0.45
CES1 P23141 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
PLK1 P53350 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MEN1 O00255 1/20 0.43
EPHX2 P34913 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5806173 0.82 ESR1 (0.52) ALDH1A1LMNAHSD17B10CA1CA2
SCHEMBL2517938 0.82 KCNN4 (0.50) MAPTALDH1A1ALOX15MAPK1HSD17B10
SCHEMBL22722985 0.82 KCNN4 (0.50) MAPTALDH1A1ALOX15MAPK1HSD17B10
SCHEMBL5046100 0.82 KCNN4 (0.50) MAPTALDH1A1ALOX15MAPK1HSD17B10
SCHEMBL28170034 0.81 MAPT (0.41) MAPTALDH1A1LMNAMAPK1TDP1
SCHEMBL1533098 0.81 SMN1; SMN2 (0.43) MAPTALDH1A1MAPK1CES2CES1
SCHEMBL7358417 0.80 MAPT (0.53) MAPTALDH1A1LMNAALOX15APEX1
SCHEMBL1939457 0.80 AKR1C3 (0.54) MAPTALDH1A1LMNAALOX15APEX1
SCHEMBL6288747 0.78 MAPT (0.51) MAPTALDH1A1LMNAALOX15APEX1
SCHEMBL6404526 0.78 MAPT (0.51) MAPTALDH1A1LMNAALOX15APEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112682031-A Oil field interwell tracer, tracing method and fracturing fluid 中国石油化工股份有限公司 2021-04-20 CN disclosed
EP-1644362-A2 INDOLINONE HYDRAZIDES AS C-MET INHIBITORS Sugen, Inc. (US) 2006-04-12 EP disclosed
US-20060009493-A1 Indolinone hydrazides as c-Met inhibitors SUGEN, INC. 2006-01-12 US disclosed
WO-2005005378-A2 INDOLINONE HYDRAZIDES AS C-MET INHIBITORS SUGEN, INC. (US) 2005-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060009493-A1 Indolinone hydrazides as c-Met inhibitors MET, IGF1R, ROS1 MAPT 3977/4885ALDH1A1 143/4885LMNA 1980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.